Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析

◆英語タイトル:Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1301
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Zimmer Biomet Holdings Inc (ZBH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company that focuses on musculoskeletal healthcare. The company designs, manufactures, and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and thoracic products; office based technologies; dental implants; and related surgical products. Its products and solutions assist in treating patients suffering from disorders or injuries in bones, joints and supporting soft tissues. Zimmer Biomet offers products to orthopaedic surgeons, oral surgeons, neurosurgeons, other specialists, dentists, stocking distributors, hospitals, healthcare dealers and healthcare purchasing organizations. The company markets products through direct sales channels and distributors in Americas, Europe, Asia-Pacific, the Middle East and Africa. Zimmer Biomet is headquartered in Warsaw, Indiana, the US.

Zimmer Biomet Holdings Inc Key Recent Developments

Mar 10,2020: Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2020
Feb 28,2020: Zimmer Biomet Holdings to Present at Raymond James & Associates’ 41st Annual Institutional Investors Conference
Feb 04,2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
Jan 08,2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Zimmer Biomet Holdings Inc – Key Facts
Zimmer Biomet Holdings Inc – Key Employees
Zimmer Biomet Holdings Inc – Key Employee Biographies
Zimmer Biomet Holdings Inc – Major Products and Services
Zimmer Biomet Holdings Inc – History
Zimmer Biomet Holdings Inc – Company Statement
Zimmer Biomet Holdings Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Zimmer Biomet Holdings Inc – Business Description
Product Category: Dental
Overview
Performance
Product Category: Hips
Overview
Performance
Product Category: Knees
Overview
Performance
Product Category: Other
Overview
Performance
Product Category: S.E.T
Overview
Performance
Product Category: Spine & CMF
Overview
Performance
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: Asia Pacific
Target Markets
Performance
Geographical Segment: EMEA
Target Markets
Performance
R&D Overview
Zimmer Biomet Holdings Inc – Corporate Strategy
Zimmer Biomet Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
Zimmer Biomet Holdings Inc – Strengths
Zimmer Biomet Holdings Inc – Weaknesses
Zimmer Biomet Holdings Inc – Opportunities
Zimmer Biomet Holdings Inc – Threats
Zimmer Biomet Holdings Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer
Nov 05, 2019: Zimmer Biomet announces third quarter 2019 financial results
Jul 26, 2019: Zimmer Biomet announces second quarter 2019 financial results
Jun 19, 2019: Zimmer Biomet announces chief financial officer transition plan
Apr 26, 2019: Zimmer Biomet announces first quarter 2019 financial results
Feb 01, 2019: Zimmer Biomet announces fourth quarter and full-year 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Zimmer Biomet Holdings Inc, Key Facts
Zimmer Biomet Holdings Inc, Key Employees
Zimmer Biomet Holdings Inc, Key Employee Biographies
Zimmer Biomet Holdings Inc, Major Products and Services
Zimmer Biomet Holdings Inc, History
Zimmer Biomet Holdings Inc, Subsidiaries
Zimmer Biomet Holdings Inc, Key Competitors
Zimmer Biomet Holdings Inc, Ratios based on current share price
Zimmer Biomet Holdings Inc, Annual Ratios
Zimmer Biomet Holdings Inc, Annual Ratios (Cont...1)
Zimmer Biomet Holdings Inc, Annual Ratios (Cont...2)
Zimmer Biomet Holdings Inc, Interim Ratios
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Zimmer Biomet Holdings Inc, Performance Chart (2015 - 2019)
Zimmer Biomet Holdings Inc, Ratio Charts
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tundra Oil & Gas Partnership:石油・ガス:M&Aディール及び事業提携情報
    Summary Tundra Oil & Gas Partnership (Tundra), a subsidiary of James Richardson & Sons, Limited is an oil and gas company that offers asset development services. The company produces and markets light sweet crude oil in southeastern Saskatchewan and southwestern Manitoba. It explores and produces na …
  • RWE AG:企業の戦略・SWOT・財務情報
    RWE AG - Strategy, SWOT and Corporate Finance Report Summary RWE AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • CESC Ltd (CESC):企業の財務・戦略的SWOT分析
    CESC Ltd (CESC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Sanofi-Aventis Korea Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi-Aventis Korea Co Ltd (Sanofi-Aventis), a subsidiary of Sanofi is a developer, manufacturer and distributor of generic drugs and medical equipment. The company’s products include note vials lantus, lantus state solo star, she feeds the main vial la, feed her a solo star la shares, elro …
  • Cincinnati Financial Corp:企業の戦略・SWOT・財務情報
    Cincinnati Financial Corp - Strategy, SWOT and Corporate Finance Report Summary Cincinnati Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bank Of Ningbo Co. Ltd.:企業の戦略・SWOT・財務分析
    Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Northwest Territories Power Corporation:発電所・企業SWOT分析
    Northwest Territories Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Edinburgh Bioquarter:製薬・医療:M&Aディール及び事業提携情報
    Summary Edinburgh Bioquarter (BioQuarter) is an academic medical center that offers translational medicine research services. The center develops new treatments for human and animal diseases by creating new drugs, diagnostic tools and medical devices. It conducts research in the field of regenerativ …
  • Marafiq:企業の戦略的SWOT分析
    Marafiq - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Capgemini SE:企業の戦略・SWOT・財務情報
    Capgemini SE - Strategy, SWOT and Corporate Finance Report Summary Capgemini SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Citizens Financial Corp.:企業の戦略・SWOT・財務情報
    Citizens Financial Corp. - Strategy, SWOT and Corporate Finance Report Summary Citizens Financial Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Charles River Laboratories International, Inc.:戦略・SWOT・企業財務分析
    Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • ProteoMediX AG:医療機器:M&Aディール及び事業提携情報
    Summary ProteoMediX AG (ProteoMediX) is a medical diagnostic company that identifies and develops novel biomarkers for the early detection of cancer and the personalized treatment. The company develops non-invasive diagnostic tests for the detection, prognosis, stratification, and therapy-selection …
  • Nobelpharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company that develops medicines for rare diseases and unmet medical needs. The company’s pipeline products include NPC-09, NPC-12, NPC-15, NPC-16, NPC-17 and NPC-18. It offers products in the therapeutic areas of oncology, metabolic diseas …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437)-製薬・医療分野:企業M&A・提携分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products comprise pharmaceutical drugs for treating nutrition disorders, cardiovascular diseases, cancer and musculoskeletal disorders. Its pipeline pro …
  • Arsenal Holdings PLC:企業の戦略的SWOT分析
    Arsenal Holdings PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Tan Viet Securities Joint Stock Company:企業の戦略的SWOT分析
    Tan Viet Securities Joint Stock Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Dermira Inc (DERM):製薬・医療:M&Aディール及び事業提携情報
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Amgen Inc (AMGN)-製薬・医療分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • Carlsberg A/S:企業の戦略・SWOT・財務情報
    Carlsberg A/S - Strategy, SWOT and Corporate Finance Report Summary Carlsberg A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆